share_log

Cantor Fitzgerald Reiterates Overweight on KalVista Pharmato Overweight

Benzinga ·  Dec 9 22:55

Cantor Fitzgerald analyst Pete Stavropoulos reiterates KalVista Pharma (NASDAQ:KALV) from Overweight to Overweight.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment